Ceribell IPO

ceribell.com

Ceribell is the developer of a highly innovative electroencephalography (EEG) device, designed to make the diagnosis of neurological patients drastically more efficient.

Founded2014
Total Funding to Date$153.26MM
Register for Details

For more details on financing and valuation for Ceribell, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Ceribell Ticker Symbol

Ceribell does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Ceribell Stock Price

The stock price for Ceribell will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Ceribell Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/22/2022 Series C-1 and C-NV $102.69MM raised $XXX.XX $XXX.XX
9/25/2018 Series B $36.08MM raised $XXX.XX $XXX.XX
5/3/2017 Series A $13.49MM raised $XXX.XX $XXX.XX
8/31/2015 Series Seed $1,000K raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Ceribell in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector